ProShares Ultra Nasdaq Biotechnology 2X Shares Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 6.44 K | $513.54 K | -54.35% | 0.77% |
| CAPITAL INVESTMENT ADVISORS, LLC | 01/13/2026 | 6.00 K | $478.37 K | -1.64% | 0.71% |
| KAIZEN FINANCIAL STRATEGIES | 01/21/2026 | 5.32 K | $424.03 K | 100.00% | 0.63% |
| CITADEL ADVISORS LLC | 02/17/2026 | 4.90 K | $390.92 K | 100.00% | 0.58% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 4.00 K | $319.12 K | -25.93% | 0.48% |
| PALUMBO WEALTH MANAGEMENT LLC | 01/21/2026 | 4.00 K | $319.12 K | -68.87% | 0.48% |
| TOTH FINANCIAL ADVISORY CORP | 01/20/2026 | 997 | $79.54 K | 0.00% | 0.12% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/17/2026 | 938 | $74.83 K | 68.10% | 0.11% |
| ROYAL BANK OF CANADA | 02/17/2026 | 800 | $64.00 K | 0.00% | 0.10% |
| FRANKLIN RESOURCES INC | 02/11/2026 | 696 | $55.53 K | 0.00% | 0.08% |
| PNC FINANCIAL SERVICES GROUP, INC. | 02/06/2026 | 500 | $39.89 K | 0.00% | 0.06% |
| MAI CAPITAL MANAGEMENT | 02/13/2026 | 250 | $19.95 K | 0.00% | 0.03% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 02/10/2026 | 204 | $16.28 K | 0.00% | 0.02% |
| HAREL INSURANCE INVESTMENTS & FINANCIAL SERVICES LTD. | 02/03/2026 | 198 | $16.00 K | 0.00% | 0.02% |
| TRUVESTMENTS CAPITAL LLC | 02/13/2026 | 125 | $9.97 K | 0.00% | 0.01% |
| WHITTIER TRUST CO | 01/26/2026 | 75 | $6.10 K | 0.00% | 0.01% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 53 | $4.23 K | 0.00% | 0.01% |
| SIMPLEX TRADING, LLC | 02/11/2026 | 12 | $957 | 100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 2 | $145 | 100.00% | 0.00% |
| MORGAN STANLEY | 02/13/2026 | 1 | $125 | 0.00% | 0.00% |
| UBS GROUP AG | 01/29/2026 | 1 | $80 | 0.00% | 0.00% |
| CHASE INVESTMENT COUNSEL CORP | 02/05/2026 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
ProShares Ultra Nasdaq Biotechnology 2X Shares institutional Ownership - FAQ's
During the previous two years, 32 institutional investors and hedge funds held shares of ProShares Ultra Nasdaq Biotechnology 2X Shares. The most heavily invested institutionals were:
SUSQUEHANNA INTERNATIONAL GROUP, LLP: 6,437
Capital Investment Advisors, LLC: 5,996
Kaizen Financial Strategies: 5,315
Palumbo Wealth Management LLC: 4,000
TOTH FINANCIAL ADVISORY CORP: 997
Tower Research Capital LLC (TRC): 938
3.17% of ProShares Ultra Nasdaq Biotechnology 2X Shares stock is owned by institutional investors.
Institutional investors have bought a total of 136.13 K shares in the last 24 months. This purchase volume represents approximately $12.00 M in transactions.